Current controversies concerning sentinel lymph node biopsy for breast cancer

Breast Cancer Research and Treatment

Volumn 84, Issue 3, 2004, Pages 261-271

  Noguchi, Masakuni ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Breast cancer; Sentinel lymph node biopsy

Indexed keywords

DYE; EOSIN; HEMATOXYLIN; RADIOISOTOPE;

ADJUVANT CHEMOTHERAPY; ARTICLE; AXILLARY LYMPH NODE; BREAST CALCIFICATION; BREAST CANCER; BREAST SURGERY; CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; DIAGNOSTIC ACCURACY; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMPRESSION CYTOLOGY; INJECTION; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MASS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY; STAINING; SURGEON;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 1842482581     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000019952.55284.f2     Document Type: Review

References (84)

1. Turner RR, Ollila DW, Krasne DL et al.: Histopathologic validation of the sentinel node hypothesis for breast carcinoma. Ann Surg 226: 271-278, 1997
2. Veronesi U, Paganelli G, Galimberti V et al.: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349: 1864-1867, 1997
3. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph nodes in breast cancer. Lancet 349: 1668-1669, 1997
4. Linehan DC, Hill AD, Akhurst T et al.: Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 6: 450-454, 1999
5. Roumen RMH, Valkenburg JGM, Gueskens LM: Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 23: 495-502, 1997
6. Klimberg VS, Rubio IT, Henry R et al.: Subareolar versus peritumoral injection for location of the sentinel lymph node. Am Surg 6: 860-865, 1999
7. Kern KA: Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 189: 539-545, 1999
8. Bauer TW, Spitz FR, Callans LS et al.: Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 9: 169-176, 2002
9. Roumen RMH, Gueskens LM, Valkenburg JGH: In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol 25: 347-351, 1999
10. Tanis PJ, Nieweg OE, Valdes Olmos RA et al.: Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 192: 390-409, 2001
11. McMasters K, Wong S, Martin R et al.: Dermal injection of radioactive colloid is superior to peritumoral injections for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233: 676-687, 2001
12. Kern KA: 'Reply' on lymphoscintigraphic anatomy of sentinel lymphatic channels. J Am Coll Surg 194: 846-848, 2002
13. Canavese G, Gipponi M, Catturich A et al.: Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients. J Surg Oncol 74: 69-74, 2000
14. Burak WE, Walker MJ, Yee LD et al.: Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 177: 445-449, 1999
15. McMasters KM, Wong SL, Tuttle TM et al.: Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 231: 724-731, 2000
16. Noguchi M, Tsugawa K, Miwa K et al.: Sentinel lymph node biopsy in breast cancer using blue dye with or without isotope localization. Breast Cancer 7: 287-296, 2000
17. Bass SS, Cox CE, Ku NN et al.: The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 189: 183-194, 1999
18. Benamor M, Nos C, Freneaux P et al.: Impact of internal mammary sentinel node imaging in breast cancer. Clin Nucl Med 28: 375-378, 2003
19. Uren RF, Howman-Giles RB, Thompson JF et al.: Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36: 1775-1780, 1995
20. O'Hea BJ, Hill ADK, El-Shirbiny AM et al.: Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186: 423-427, 1998
21. Krag D, Weaver D, Ashikaga T et al.: The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 339: 941-946, 1998
22. Veronesi U, Valagussa P: Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 47: 170-175, 1981
23. Veronesi U, Marubini E, Mariani L et al.: The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomized trial. Eur J Cancer 35: 1320-1325, 1999
24. Veronesi U, Cascinelli N, Greco M et al.: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202: 702-707, 1985
25. Noguchi M, Ohta N, Koyasaki N et al.: Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer 68: 1918-1925, 1991
26. Goldhirsch A, Glick JH, Gelber RD et al.: Meeting high-lights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 19: 3817-3327, 2001
27. Noguchi M, Tsugawa K, Miwa K: Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol 73: 75-80, 2000
28. Johnson N, Soot L, Nelson J et al.: Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg 179: 386-388, 2000
29. Van der Ent FWC, Kengen RAM, van der Pol HAG et al.: Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 234: 79-84, 2001
30. Freedman GM, Fowble BL, Nicolaou N et al.: Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 46: 805-814, 2000
31. Winchester DJ, Sener SF, Winchester DP et al.: Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients: efficacy of filtered technetium 99m sulfur colloid with overnight migration time. J Am Coll Surg 188: 597-603, 1999
32. Gulec SA, Moffat FL, Carroll RG et al.: Sentinel lymph node localization in early breast cancer. J Nucl Med 39: 1388-1393, 1998
33. Lucci Jr A, Kelemen PR, Miller III C, et al.: National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 192: 453-458, 2001
34. Veronesi U, Cascinelli N, Bufalino R et al.: Risk of internal mammary lymph-node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 198: 681-684, 1983
35. Noguchi M, Michigishi T, Nakajima K et al.: The diagnosis of internal mammary node metastases of breast cancer. Int Surg 78: 171-175, 1993
36. Galimberti V, Veronesi P, Arnone P et al.: Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol 9: 924-928, 2002
37. Noguchi M: Internal mammary sentinel node biopsy for breast cancer: is it practicable and relevant? (Review). Oncol Report 9: 461-468, 2002
38. Veronesi U, Paganelli G, Galimberti V et al.: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349: 1864-1867, 1997
39. Viale G, Bosari S, Mazzarol G et al.: Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85: 2433-2438, 1999
40. Rubio IT, Korourian S, Cowan C et al. : Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 5: 689-694, 1998
41. Schwartz GF, Giuliano AE, Veronesi U et al.: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, 19-22 April 2002, Philadelphia, PA, USA. Breast J 8: 126-138, 2002
42. Motomura K, Inaji H, Komoike Y et al.: Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg 87: 597-601, 2000
43. Henry-Tillman RS, Korourian S, Rubio IT et al.: Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience. Ann Surg Oncol 9: 333-339, 2002
44. Lee A, Krishnamurthy S, Sahin A et al.: Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer 96: 225-231, 2002
45. Llatjos M, Castella E, Fraile M et al.: Intraoperative assessment of sentinel lymph nodes in patients with breast carcinoma. Accuracy of rapid imprint cytology compared with definitive histologic workup. Cancer Cytopathol 96: 150-156, 2002
46. Dowlatshahi K, Fan M, Snider HC et al.: Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80: 1188-1197, 1997
47. Dowlatshahi K, Fan M, Bloom KJ, et al.: Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. A preliminary study. Cancer 86: 990-996, 1999
48. Tjan-Heijnen VCG, Bult P, de Widt-Levert LM et al.: Micrometastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70: 81-88, 2001
49. Turner RR, Chu KU, Qi K et al.: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast cancer in a sentinel lymph node. Cancer 89: 574-581, 2000
50. Rosen PP, Lesse ML, Kinne DW et al.: Discontinuous or 'skip' metastasis in breast carcinoma: analysis of 1228 axillary dissections. Ann Surg 97: 276-283, 1983
51. Czerniecki BJ, Scheff AM, Callans LS et al.: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85: 1098-1103, 1999
52. Chu KU, Turner RR, Hansen NM et al.: Do all patients with sentinel node metastases from breast carcinoma need complete axillary node dissection? Ann Surg 229: 536-541, 1999
53. Reynolds C, Mick R, Donohue JH et al.: Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17: 1720-1726, 1999
54. Viale G, Maiorano E, Mazzarol G et al.: Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92: 1378-1384, 2001
55. den Bakker MA, van Weeszenberg A, de Kanter AY et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol 55: 932-935, 2002
56. Hsueh EC, Turner RR, Glass EC et al.: Sentinel node biopsy in breast cancer. J Am Coll Surg 189: 207-212, 1999
57. Cody HS III.: Sentinel lymph node mapping in breast cancer. Breast Cancer 6: 13-22, 1999
58. Noguchi M.: Sentinel lymph node biopsy in breast cancer. Br J Surg 89: 21-34, 2002
59. Chung MA, DiPetrillo T, Hernandez S et al.: Treatment of the axilla by tangential breast radiotherapy in women with invasive breast cancer. Am J Surg 184: 401-402, 2002
60. Klauber-DeMore N, Tan LK, Liberman L et al.: Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 7: 636-642, 2000
61. Cox CE, Nguyen K, Gray RJ et al.: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67: 513-519, 2001
62. Wasserberg N, Morgenstern S, Schachter J et al.: Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component. Arch Surg 137: 1249-1252, 2002
63. Intra M, Veronesi P, Mazzarol G et al.: Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138: 309-313, 2003
64. Pendas S, Dauway E, Giuliano R et al.: Sentinel node biopsy in DCIS patients. Ann Surg Oncol 7: 15-20, 2000
65. Lagios MD, Silverstein MJ: Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 8: 275-277, 2001
66. Cox CE, Pendas S, Cox IM et al.: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227: 645-653, 1998
67. Breslin TM, Cohen L, Sahin A et al.: Sentinel node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18: 3480-3486, 2000
68. Nason KS, Anderson BO, Byrd DR et al.: Increased false negative sentinel lymph node biopsy rates after preoperative chemotherapy for invasive breast cancer. Cancer 89: 2187-2194, 2000
69. Haid A, Tausch C, Lang A et al.: Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 92: 1080-1084, 2001
70. Piato JRM, Brros ACSD, Pincerato KM et al.: Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. EJSO 29: 118-120, 2002
71. Mamounas E, Brown A, Smith R et al.: Sentinel node biopsy (SNB) following neoadjuvant chemotherapy in breast cancer (BC): results from NSABP B-27. Society of Surgical Oncology 54th Annual Cancer Symposium, March 2001.
72. Cohen LF, Breslin TM, Kuerer HM et al.: Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Pathol 24: 1266-1272, 2000
73. Anderson BO, Jewell K, Eary JF et al.: Neoadjuvant chemotherapy contraindicates sentinel node mapping in breast cancer. Proc ASCO 18: 71a, 1999
74. Julian TB, Patel N, Dusi D et al.: Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 182: 407-410, 2001
75. Hunt KK, Ross MI: Lymphatic mapping for breast cancer: surgical advance in evolution. Oncology 12: 1297-1298, 1998
76. Noguchi M: Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary dissection? Breast Cancer 10: 179-187, 2003
77. McNeil C: Four large studies aim to resolve sentinel node debate. J Natl Cancer Inst 90: 729, 1998
78. Noguchi M: Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary dissection? Breast Cancer 10: 179-187, 2003
79. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A et al.: Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 77: 165-170, 2001
80. Roumen RMH, Kuijt GP, Liem IH et al.: Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 88: 1639-1643, 2001
81. Giuliano AE, Haigh PI, Brennan MB et al.: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18: 2553-2559, 2000
82. Noguchi M: Sentinel lymph node biopsy in breast cancer: an overview of the Japanese experience. Breast Cancer 8: 184-194, 2001
83. Reitsamer R, Peintinger F, Prokop E et al.: Sentinel lymph node biopsy alone without axillary lymph node dissection - follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 29: 211-223, 2003
84. Tafra L, Lannin DR, Swanson MS et al.: Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233: 51-59. 2001